6JKJ
Crystal structure of human SPSB2 in the apo-state
Summary for 6JKJ
| Entry DOI | 10.2210/pdb6jkj/pdb |
| Descriptor | SPRY domain-containing SOCS box protein 2 (2 entities in total) |
| Functional Keywords | e3 ubiquitin ligase, spry domain-containing socs box protein, spsb2, protein binding |
| Biological source | Homo sapiens (Human) |
| Total number of polymer chains | 2 |
| Total formula weight | 45793.21 |
| Authors | |
| Primary citation | Luo, Y.,Li, K.,Yang, J.,Zhang, D.,Zhou, Y.,Kuang, Z. Crystal structure of the SPRY domain of human SPSB2 in the apo state. Acta Crystallogr.,Sect.F, 75:412-418, 2019 Cited by PubMed Abstract: The SPRY domain-containing SOCS box protein 2 (SPSB2) is one of four mammalian SPSB proteins that are characterized by a C-terminal SOCS box and a central SPRY/B30.2 domain. SPSB2 interacts with inducible nitric oxide synthase (iNOS) via the SPRY domain and polyubiquitinates iNOS, resulting in its proteasomal degradation. Inhibitors that can disrupt SPSB2-iNOS interaction and augment NO production may serve as novel anti-infective and anticancer agents. The previously determined murine SPSB2 structure may not reflect the true apo conformation of the iNOS-binding site. Here, the crystal structure of human SPSB2 SPRY domain in the apo state is reported at a resolution of 1.9 Å. Comparison of the apo and ligand-bound structures reveals that the iNOS-binding site is highly preformed and that major conformational changes do not occur upon ligand binding. Moreover, the C-terminal His tag of the recombinant protein binds to a shallow pocket adjacent to the iNOS-binding site on a crystallographically related SPSB2 molecule. These findings may help in structure-based and fragment-based SPSB2 inhibitor design in the future. PubMed: 31204687DOI: 10.1107/S2053230X1900623X PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (1.9 Å) |
Structure validation
Download full validation report






